Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

qCON/qNOX-guided anesthesia for thyroidectomy

Official title: The Effect of qCON/qNOX-Guided Anesthesia Using the Conox Monitor on Clinical Outcomes in Patients Undergoing Thyroidectomy Surgery

Run by Kayseri City Hospital · NCT07445659 · Data updated 2026-11-12

This trial will test whether using the Conox qCON/qNOX monitor during thyroid surgery reduces intraoperative opioid use and speeds recovery for adults having a thyroidectomy.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment90 (estimated)
SponsorKayseri City Hospital
Government
Locations1 site (Kayseri, Kayseri)
StatusRecruiting
StartedApril 10, 2026
Main results expectedJune 1, 2026
Study endsJune 30, 2026
Registry record updatedApril 20, 2026
Trial IDNCT07445659 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with ASA physical status I–II scheduled for thyroidectomy who can have EEG electrodes placed and can give informed consent are the ideal candidates.

Probably not a fit

Patients with skin lesions that prevent EEG placement, preexisting neurological disorders, an anticipated difficult airway, or those outside the age/ASA criteria are unlikely to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing thyroidectomy at Kayseri City Hospital will receive either Conox-guided anesthesia with qCON/qNOX monitoring or standard anesthesia management, with maintenance by inhalational agents and opioids and no additional neuromuscular blockers after induction. The primary outcome is intraoperative opioid consumption, with secondary outcomes including recovery time, postoperative agitation rates, and pain scores. Investigators will record qCON and qNOX indices and correlate them with conventional hemodynamic parameters to explore their relationship with nociception and anesthetic depth. Standard eligibility rules apply (age 18–70, ASA I–II) and EEG electrode placement is required unless prevented by skin lesions.

Why it matters

Potential benefit: If successful, Conox-guided anesthesia could reduce opioid use during surgery and shorten recovery and discomfort after thyroidectomy.

How similar studies have gone: Some prior studies of nociception monitoring have shown reduced intraoperative opioid use and better hemodynamic control, but results are mixed and the specific use of qCON/qNOX in thyroidectomy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18-70 years
* Thyroidectomy cases with ASA physical status I-II
* Patients who have provided written informed consent

Exclusion Criteria:

* Skin lesions preventing EEG electrode placement
* Neurological disorders (e.g., epilepsy)
* Anticipated difficult airway

Where it's running

  • Kayseri City Hospital
    Kayseri, Kayseri, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: çiğdem ünal kantekin, MD — Kayseri City Hospital
  • Study coordinator: Çiğdem Ünal Kantekin, MD
  • Email: drcgdm@gmail.com
  • Phone: +905054433056

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.